CORESTEMCHEMON Company Description

CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS).

The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases.

The company was formerly known as Corestem, Inc. CORESTEMCHEMON Inc. was founded in 2003 and is based in Seongnam-si, South Korea.

CORESTEMCHEMON Inc.

Country	South Korea
Founded	2003
Industry	Biological Products, Except Diagnostic Substances
Employees	355
CEO	Kyung-Suk Kim

Contact Details

Address: 24, Pangyo-ro 255beon-gil Seongnam-si, 13486 South Korea
Phone	82 2 497 3711
Website	corestem.com

Stock Details

Ticker Symbol	166480
Exchange	Korea Exchange - KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Kyung-Suk Kim	Chief Executive Officer